Alta Berri

Try to make a search...

Spirovant Continues Rapid Growth with New Headquarters and Expanded Leadership
Spirovant CEO Joan Lau Selected EY Entrepreneur of The Year^® in Greater Philadelphia
Spirovant CEO Joan Lau Selected as a Woman of Distinction by Philadelphia Business Journal
FDA Grants Spirovant Sciences Orphan Drug and Rare Pediatric Disease Designations for SPIRO-2101 for Treatment of Cystic Fibrosis
FDA Grants Spirovant Sciences Orphan Drug and Rare Pediatric Disease Designations for SPIRO-2101 for Treatment of Cystic Fibrosis

Spirovant Sciences, Inc.
3675 Market Street, Suite 200
Philadelphia, PA 19104
info@spirovant.com
(267) 244-8206